Mural Oncology plc (MURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $35.38M
Last updated: Nov 06, 2026 at 4:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the 50-day average is below the 200-day average. The 14-day RSI is 40.1, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about MURA
News
No news available
Company news will appear here when available
MURA Valuation
- P/B
- 0.6x
MURA Profitability: Margins, ROIC and FCF
Mural Oncology (MURA) has an operating margin of 0.0% and a net margin of 0.0%. It posts -173.6% ROIC.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROIC
- -173.6%
- ROE
- -103.9%
Mural Oncology Competitors
The companies most similar to Mural Oncology (MURA) include Mereo BioPharma Group PLC ADR, Oncolytics Biotech and Veru.
Sector: Healthcare
MURA Bull Case vs Bear Case
Bull case
- MURA beat EPS estimates in 75.0% of its last 8 reported quarters.
MURA Earnings: Beat Rate
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- -10.1%
Updated Mar 31, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About MURA
Does MURA pay dividends?
Mural Oncology plc (MURA) does not currently pay a regular dividend.
What is MURA's market cap?
Mural Oncology plc (MURA) has a market capitalization of $35.38M with a current stock price of $2.04.
MURA pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.